N-(5-(1H-INDOL-3-YLMETHYL)-1,3,4-THIADIAZOL-2-YL)-4-METHOXYBENZAMIDE
UNII XFD2F8FC8D

Substance Identification & Data

This profile provides standardized clinical and technical data for N-(5-(1h-indol-3-ylmethyl)-1,3,4-thiadiazol-2-yl)-4-methoxybenzamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XFD2F8FC8D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 340018-27-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

XFD2F8FC8D

CAS Registry Number

340018-27-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

N-(5-(1H-INDOL-3-YLMETHYL)-1,3,4-THIADIAZOL-2-YL)-4-METHOXYBENZAMIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H16N4O2S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

AXHAJBIEOINPDH-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

1036901

Unique identification number in the NCBI database of chemical substances.

Substance Type

N-[5-(1H-Indol-3-ylmethyl)-1,3,4-thiadiazol-2-yl]-4-methoxybenzamide

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

COc1ccc(cc1)C(=O)Nc2nnc(Cc3c[nH]c4ccccc34)s2

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for N-(5-(1h-indol-3-ylmethyl)-1,3,4-thiadiazol-2-yl)-4-methoxybenzamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.